New drug may offer quicker relief for ER patients with nausea
NCT ID NCT06382012
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a newer anti-nausea drug, fosaprepitant, to the standard medicine ondansetron for adults coming to the emergency room with nausea and vomiting. The goal is to see if fosaprepitant provides faster relief without needing extra medication. About 200 participants will receive either drug and be monitored for two hours.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NAUSEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Montefiore Medical Center (Montefiore and Weiler EDs)
RECRUITINGThe Bronx, New York, 10467, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Simple breathing exercises after gallbladder surgery may cut pain and nausea
- Could a Steroid-Sparing cocktail tame chemo nausea?
- Plasma power: new endoscopic treatment could heal Post-Bypass ulcers faster
- Sniff your way to better rehab? aromatherapy patches tested in hospital study
- Which IV fluid works best for kids with stomach bugs? new study aims to find out
- Could a simple shot replace IV drips for nausea?